Page last updated: 2024-09-04

fenton's reagent and Breast Neoplasms

fenton's reagent has been researched along with Breast Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baltić, VV; Bogdanović, G; Canadanović-Brunet, J; Dordević, A; Kojić, V; Vojinović-Miloradov, M1
Day, RO; Handel, ML; Sivertsen, S; Sutherland, RL; Watts, CK1

Other Studies

2 other study(ies) available for fenton's reagent and Breast Neoplasms

ArticleYear
Modulating activity of fullerol C60(OH)22 on doxorubicin-induced cytotoxicity.
    Toxicology in vitro : an international journal published in association with BIBRA, 2004, Volume: 18, Issue:5

    Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Combinations; Drug Screening Assays, Antitumor; Electron Spin Resonance Spectroscopy; Female; Fullerenes; Humans; Hydrogen Peroxide; Hydroxyl Radical; Iron; Spin Trapping

2004
D-penicillamine causes free radical-dependent inactivation of activator protein-1 DNA binding.
    Molecular pharmacology, 1996, Volume: 50, Issue:3

    Topics: Breast Neoplasms; Cell Nucleus; Cysteine; DNA, Neoplasm; Female; Free Radicals; Humans; Hydrogen Peroxide; Iron; Kinetics; Nuclear Proteins; Penicillamine; Polydeoxyribonucleotides; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Transcription Factor AP-1; Tumor Cells, Cultured

1996